Insomnia Market Forecast Now Available at ReportsandReports

September 20, 2010

DALLAS, September 20, 2010 /PRNewswire/ — ReportsandReports announces it
will carry Insomnia Market Forecast Research Report in its store.

    Browse the complete Report on:


Search More Then 50000 Market Research Reports at ReportsandReports

    Browse All Datamonitor Research Reports at


The availability of generic versions of Ambien (zolpidem, Sanofi-Aventis)
in the US from April 2007 onwards has intensified competition for both
existing and prospective players in the insomnia market. Following the
discontinuation of three 5-HT antagonists in late-stage development over
20092010, orexin receptor antagonists now represent the most innovative
candidates in the insomnia pipeline.

    Reasons to Purchase

    - Quantify the current and future size of the insomnia market in the
      seven major pharmaceutical markets.
    - Identify potential licensing opportunities based on product portfolios
      and anticipated market needs.
    - Understand the country-specific impact of key events in the insomnia
      market during the forecast period 2010 to 2019.

    Browse all Healthcare Reports at


About Us

ReportsandReports comprises an online library of 10,000 reports, in-depth
market research studies of over 5000 micro markets, and 25 industry specific
websites. Our client list boasts almost all well-known publishers of such
reports across the globe. We as a third-party reseller of market research
reports employ a number of marketing tools, such as press releases,
email-marketing and effective search-engine optimization techniques to drive
revenues for our clients. We also provide 24/7 online and offline support
service to our customers.

    Ms. Sunita
    7557 Rambler road
    Suite 727, Dallas, TX 75231
    Tel: +1-888-989-8004




SOURCE MarketsandMarkets

Source: newswire

comments powered by Disqus